ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000256742.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.027772801	Resistant
ENSG00000256742.1	ABT-263 (navitoclax)	Sarcoma	0.007789118	Resistant